Celyad Oncology SA (CYAD.BR) Stock Price

€0.4 0.3%

Sign up
to add to portfolio

AI Score

Sell

  • Alternative

    4

  • Fundamental

    1

  • Technical

    3

Our AI score evaluates a company's performance on a scale from 0 to 10 by analyzing alternative data points — web traffic, app downloads, job postings, etc - along with financial health and technical signals. Scores below 4 project bearish performance, while scores above 6 project bullish performance.

Sign up to get access to more historical data and insights on Celyad Oncology SA, AI stock picks, stock alerts and much more.

Sign up

CYAD.BR AI Stock Analysis

AI stock analysis for CYAD.BR is missing at the moment.

Our AI stock analysis reviews financial data, technical analysis, and alternative data insights to project stock performance. For example, analyzing a company like Celyad Oncology SA (CYAD.BR) provides a clear summary of future projections. Gain the edge you need to make confident, data-driven investment decisions.

Sign up and become a member to get access to AI stock analysis.

Sign up

Celyad Oncology SA (CYAD.BR) Price Prediction

Based on a combination of financial analysis, technical indicators, and insights from alternative data, we predict that the stock price of Celyad Oncology SA (CYAD.BR), currently trading at €0.4, will... Sign up to access price prediction.

Disclaimer:
This prediction is provided for informational purposes only and does not constitute financial advice. Market conditions are subject to change, and past performance is not indicative of future results. Please conduct your own research or consult a professional before making investment decisions.

About CYAD.BR

LSE

  • Celyad Oncology SA, a clinical-stage biopharmaceutical company, focuses on the discovery and development of chimeric antigen receptor T (CAR-T) cell therapies for the treatment of cancer.

  • Symbol

    CYAD.BR

  • Market

    EURONEXT

  • Industry

    Biotechnology

  • Market Cap

    16.6M

Similar Stocks

VLA.PA Valneva SE
VLA.PA		 €3.93
22.2%
5
TUB.BR Financière de Tubize SA
TUB.BR		 €162.6
1.3%
8
OSE.PA OSE Immunotherapeutics SA
OSE.PA		 €6.15
2.7%
6
UCB.BR UCB SA
UCB.BR		 €201
1.9%
6
IPH.PA Innate Pharma S.A.
IPH.PA		 €1.95
3%
5

News

Cardiac Valve Repair Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies

Cardiac Valve Repair Devices Pipeline Research Report 2024: Stages of Development, Segments, Region and Countries, Regulatory Path and Key Companies
August 6, 2024. GlobeNewswire

CYAD.BR Alternative Data

Web Traffic

Celyad Oncology SA receives an estimated 1486 monthly visitors to celyad.com.

  • Web Traffic

    1486

  • Change from Previous Month

    81.7%

  • 3 Month Change

    46.4%

  • YoY Change

    46.4%

Twitter Followers

Celyad Oncology SA has 2,269 Twitter Followers on its main Twitter (also known as X) account, which is down by -0.1% over the last month.

  • Twitter Followers

    2269

  • Daily Change

    0%

  • 1 Month Change

    0.1%

  • 3 Month Change

    0.4%

  • YoY Change

    0.4%

Youtube Subscribers

Celyad Oncology SA has 493 subscribers on its main Youtube channel.

  • Youtube Subscribers

    493

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0.2%

Job Postings

Celyad Oncology SA currenly has an estimated 0 open job postings.

  • Job Postings

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

LinkedIn Employees

According to LinkedIn, Celyad Oncology SA has 31 employees, up by 3.3% over the last month.

  • LinkedIn Employees

    31

  • Daily Change

    3.3%

  • 1 Month Change

    3.3%

  • 3 Month Change

    3.3%

  • YoY Change

    3.3%

Business Outlook

According to employee reviews, the business outlook among employees at Celyad Oncology SA is 28 out of 100 (bearish).

  • Business Outlook

    28

  • Change from Previous Month

    24.3%

  • 3 Month Change

    24.3%

  • YoY Change

    24.3%

News Mentions

Celyad Oncology SA was mentioned 0 times in the news yesterday.

  • News Mentions

    0

  • Daily Change

    0%

  • 1 Month Change

    0%

  • 3 Month Change

    0%

  • YoY Change

    0%

Reddit Mentions

Celyad Oncology SA has been mentioned an estimated 0 times in investment subreddits on Reddit over the last 24 hours.

  • Reddit Mentions

    0

  • 1 Month Change

    0%

  • 3 Month Change

    0%

CYAD.BR Financials

CYAD.BR Key Metrics

  • Total Revenue

    €172K

  • Net Income

    -€2.8M

  • Earnings per Share

    -€0.0671

  • Free cash flow

    -€2.8M

  • EBITDA

    -€2.6M

  • EBITDA Ratio

    -15.1279

  • Total Assets

    €9.9M

CYAD.BR 2-year Revenue & Income
CYAD.BR 2-year Free Cash Flow

CYAD.BR Technicals

CYAD.BR SMA
CYAD.BR RSI

FAQ

What's the current price of Celyad Oncology SA (CYAD.BR) Stock?
The price of an Celyad Oncology SA (CYAD.BR) share is €0.4.

What's the market cap of Celyad Oncology SA?
The current market cap of Celyad Oncology SA is 16.6M.

Should I buy or sell CYAD.BR?
Celyad Oncology SA exhibits several negative alternative data signals, leading us to expect continued underperformance in the coming months. As a result, we maintain a negative outlook on this stock.

Is Celyad Oncology SA a good investment?
Considering the fundamentals, technical analysis, and alternative data insights, it may not be the best time to invest in Celyad Oncology SA stock. There are several bearish signals and market challenges that could negatively impact Celyad Oncology SA's future performance, suggesting that caution should be exercised before making any investment decisions.

Is now a good time to buy Celyad Oncology SA (CYAD.BR) Stock?
Based on an analysis that includes fundamentals, technical analysis, and alternative data insights, it may not be the best time to buy Celyad Oncology SA stock right now, as the outlook appears bearish.

What are some stocks similar to Celyad Oncology SA (CYAD.BR) that investors often compare it to?
Celyad Oncology SA (CYAD.BR) is often compared to similar stocks such as Valneva SE, Financière de Tubize SA, OSE Immunotherapeutics SA, UCB SA and Innate Pharma S.A..

What is the forecast for Celyad Oncology SA's stock price in 2026?
Using a mix of financial analysis, technical indicators, and alternative data, we forecast Celyad Oncology SA's stock price to be around €0.371 in 2026. Starting from the current price of €0.4, this represents a 7.3% change in price, indicating a bearish outlook for the stock.

How to buy Celyad Oncology SA (CYAD.BR) Stock?
Celyad Oncology SA stock is available for purchase through numerous brokerage firms, including online platforms. Investors can also buy Celyad Oncology SA shares via trading apps on their smartphones or by utilizing services like robo-advisors for automated investing.